References
- Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol 2012;13:11-23. https://doi.org/10.1007/s11864-011-0171-3
- Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab 2001;86:485-493. https://doi.org/10.1210/jcem.86.2.7207
- Walgenbach S, Hommel G, Junginger T. Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study. World J Surg 2000;24:564-569. https://doi.org/10.1007/s002689910092
- Chiba Y, Satoh K, Ueda S, Kanazawa N, Tamura Y, Horiuchi T. Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism. Endocr J 2007;54:379-383. https://doi.org/10.1507/endocrj.K06-152
- dell'Erba L, Baldari S, Borsato N, et al. Retrospective analysis of the association of nodular goiter with primary and secondary hyperparathyroidism. Eur J Endocrinol 2001;145:429-434. https://doi.org/10.1530/eje.0.1450429
Cited by
- Parathyroid Cancer: Comparison with Benign Hyperparathyroidism vol.19, pp.2, 2017, https://doi.org/10.16956/jes.2019.19.2.35
- Simultaneous presentation of parathyroid carcinoma, papillary thyroid cancer and ACTH-independent hypercortisolism due to benign cortical adenoma vol.12, pp.9, 2017, https://doi.org/10.1136/bcr-2019-230438
- A review of parathyroid mass and patients with nonspecific complaints vol.48, pp.1, 2017, https://doi.org/10.1177/0300060519827169
- Synchronous symptomatic parathyroid carcinoma and parathyroid adenoma with incidental follicular thyroid carcinoma vol.102, pp.8, 2017, https://doi.org/10.1308/rcsann.2020.0101
- Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma-A Rare, Highly Malignant Subtype vol.12, pp.None, 2021, https://doi.org/10.3389/fendo.2021.793718
- Synchronous intrathyroidal parathyroid carcinoma and thyroid carcinoma: case report and review of the literature vol.21, pp.1, 2017, https://doi.org/10.1186/s12902-021-00724-7